These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4704283)

  • 21. Cancer morbidity in rheumatoid arthritis patients treated with Proresid or parenteral gold.
    Bendix G; Bjelle A; Holmberg E
    Scand J Rheumatol; 1995; 24(2):79-84. PubMed ID: 7747148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Considerations on the use of Proresid (SPI-SPG Sandoz) as an adjuvant in the treatment of tumors (preliminart communication)].
    Motti VJ
    Hospital (Rio J); 1968 Oct; 74(4):1377-88. PubMed ID: 5304166
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cyclophosphamide therapy of chronic polyarthritis].
    Demetriades P; Wesiroglou G; Mitseas C; Kontomerkos A
    Med Monatsschr; 1972 Sep; 26(9):439-41. PubMed ID: 5082180
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of rheumatoid arthritis with immunosuppressive agents. Review of literature and personal cases. Results in 45 patients treated with cyclophosphamide for 6 years].
    Frizziero L; Zizzi F; Facchini A; Zini G; Ferruzzi A; Mariani E
    Recenti Prog Med; 1981 Dec; 71(6):612-40. PubMed ID: 7041209
    [No Abstract]   [Full Text] [Related]  

  • 25. [Our experience of chronic rheumatic polyarthritis therapy with immunosuppressive agents. Apropos of 41 cases].
    Arlet J; Mole J; Debrock J
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):771-4. PubMed ID: 5152709
    [No Abstract]   [Full Text] [Related]  

  • 26. [Primary immune reactions in patients with chronic polyarthritis under cytostatic ("immunosuppressive") therapy].
    Krull P; Fricke R; Wittenborg A; Deicher H
    Z Rheumaforsch; 1972; 31(5):202-9. PubMed ID: 5065469
    [No Abstract]   [Full Text] [Related]  

  • 27. The results of treatment of far-advanced highly active forms of rheumatoid arthritis with immunosuppressive agents: proresid and endoxan.
    Wawrzyńska-Pagowska J; Juszczyk T; Michalski J; Wójcik-Scislowska M
    Reumatologia; 1970; 8(4):289-97. PubMed ID: 5533055
    [No Abstract]   [Full Text] [Related]  

  • 28. [Behavior of the rheumatoid factor under long-term penicillamine therapy in primary chronic polyarthritis and lupus erythematosus disseminatus].
    Prohaska E
    Wien Z Inn Med; 1966 May; 47(5):196-202. PubMed ID: 6005164
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cytostatic and antimetabolite therapy in chronic inflammatory joint diseases and collagen diseases].
    Chlud K
    Munch Med Wochenschr; 1969 Aug; 111(32):1626-9. PubMed ID: 5394967
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of therapeutic doses of Proresid (SPI-SPG) on leukocytosis, granulocytosis and the activity of some leukocyte enzymes].
    Kotlarek-Haus S; Gabryś K
    Pol Tyg Lek; 1971 Nov; 26(47):1815-7. PubMed ID: 5132740
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of chronic rheumatoid arthritis. 6. Immunosuppression therapy in chronic rheumatoid arthritis, with special reference to the treatment with cyclophosphamide].
    Takasugi K
    Ryumachi; 1973 Oct; 13(4):374-6. PubMed ID: 4802715
    [No Abstract]   [Full Text] [Related]  

  • 32. Side effects of Proresid in the treatment of chronic arthritis.
    Weitoft T; Lysholm J
    Scand J Rheumatol; 1988; 17(1):63-6. PubMed ID: 3368755
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunosuppressive therapy of primary chronic polyarthritis and systemic lupus erythematodes disseminatus].
    Ricken D; Marsteller HJ; Baack G
    Med Welt; 1971 Sep; 39():1501-6. PubMed ID: 5106870
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacology of chemical immunosuppression].
    Potel J; Brock N
    Verh Dtsch Ges Rheumatol; 1972; 2():Suppl 2:339-57. PubMed ID: 5051958
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of the oxyphenylbutazone prednisolone combination in patients with progressive chronic polyarthritis].
    Pérez Gil L
    Rev Esp Reum Enferm Osteoartic; 1974; 17(1):45-52. PubMed ID: 4826156
    [No Abstract]   [Full Text] [Related]  

  • 36. [New aspects in rheumatism therapy. Experiences with a sitosterin preparation in chronic polyarthritis].
    Zorn J
    Med Welt; 1981 Jan; 32(4):135-8. PubMed ID: 7207146
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intra-articular hydrocortisone administration in chronic polyarthritis in ambulatory-polyclinic conditions].
    Kogut ES
    Klin Med (Mosk); 1969 Aug; 47(8):139-41. PubMed ID: 5373398
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative results of treating active, long-neglected infectious nonspecific polyarthritis under hospital conditions].
    Wawrzyńska-Pagowska I; Graff-Wróblewska T; Juszczyk T; Michalski I; Pakula A
    Vopr Revm; 1973; 13(1):76-9. PubMed ID: 4776797
    [No Abstract]   [Full Text] [Related]  

  • 39. [Long-term immunosuppressive treatment of progressive chronic polyarthritis and lupus erythematosus].
    Klein G; Möstl S
    Z Rheumaforsch; 1970; 29(3):67-74. PubMed ID: 5506505
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cyclophosphamide in rheumatoid polyarthritis. Clinical study. 45 cases. Seven year follow-up].
    Chaouat Y; Kanovitch B; Paquet J; Pélisson J; Rascovscki S; Faures B
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):751-8. PubMed ID: 5152706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.